Gabapentinoids Not Directly Associated With Risk of Self-Harm
However, increased risk of self-harm is seen before initiation of treatment, during initial phase of treatment, and after discontinuation
No Link Found Between COVID-19 Vaccination During Pregnancy and Spontaneous Abortion
Authors say findings confirm safety of COVID-19 vaccine during pregnancy
NIH Research Cuts Leave Cancer Patient Facing Hard Choice
HHS, FDA Begin ‘Operation Stork Speed’ to Improve Quality of Infant Formula
Agencies say significant progress has already been made; input has been requested from the public
Mortality Up With Loss of Low-Income Subsidy for Drugs
Mortality difference amplified for users of medications for cardiovascular disease, chronic lung disease, HIV
Previous Estimates of Illicit Opioid Use in the United States Underreported
Most individuals report that their first opioid exposure involved prescription opioids for themselves or others
U.S. Advises Older Travelers to Avoid Chikungunya Vaccine
RSV Vaccines, Nirsevimab Tied to Reduced RSV-Linked Hospitalization
Reduction in 2024-2025 RSV-associated hospitalization rates seen among infants aged 0 to 7 months with maternal vaccination or nirsevimab
Preoperative SGLT2 Inhibitor Users Have Increased Risk for Postoperative Euglycemic Ketoacidosis
Risk for postoperative eKA slightly increased; lower risks seen for perioperative acute kidney injury and 30-day mortality
Ubrogepant During Prodromal Phase of Migraine Eases Symptoms
Ubrogepant may treat prodromal symptoms, including photophobia, fatigue, phonophobia, cognitive dysfunction from as early as one hour
